Carregant...
Cardiogenic syncope possibly related to bevacizumab-containing combination chemotherapy for advanced non-small cell lung cancer
We report the case of a 55-year-old man with stage IV lung adenocarcinoma who received carboplatin-paclitaxel-bevacizumab chemotherapy as second-line therapy. After four cycles of chemotherapy, he experienced syncope with a decrease in blood pressure. Electrocardiography (ECG) revealed atrial fibril...
Guardat en:
Publicat a: | J Thorac Dis |
---|---|
Autors principals: | , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
AME Publishing Company
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059298/ https://ncbi.nlm.nih.gov/pubmed/27747019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.08.96 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|